Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414549 | PMC |
http://dx.doi.org/10.4269/ajtmh.2012.12-0108 | DOI Listing |
Strongyloides hyperinfection and disseminated infections are usually associated with immunosuppression; these severe manifestations occur in a minority of cases. The use of immunosuppressants such as corticosteroids and Baricitinib for treating COVID-19 pneumonia can be responsible for patients' immunosuppression and cause Strongyloides hyperinfection syndrome. The chance increases when the patient belongs to countries or regions where chronic infection with Strongyloides is more prevalent.
View Article and Find Full Text PDFChest
November 2024
Infectious Diseases Division, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX. Electronic address:
J Infect Public Health
August 2024
Mekong Health Science Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand; Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Rev Esp Enferm Dig
October 2024
Medical Checkup, Naha City Hospital, Japan.
Trans R Soc Trop Med Hyg
June 2024
Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil 56189-53141, Iran.
Background: It is well-documented that using immunosuppressive drugs such as corticosteroids or cytokine blockers in treating coronavirus disease 2019 (COVID-19) increases the risk of co-infections. Here we systematically summarized the cases of COVID-19-associated parasitic infections (CAPIs) in Iran.
Methods: From 19 February 2020 to 10 May 2023, all studies on Iranian patients suffering from CAPIs were collected from several databases using a systematic search strategy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!